VEGFA and cancer: In these systems, the VEGF aptamer could be controlled release mediated by the GOx-catalyzed aerobic oxidation glucose, which could inhibit the VEGF-induced generation of blood vessels and the high glucose concentrations in cancer cells, and held potentials for other disease treatment.